Familial B-cell Lymphoproliferative Disorders

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2040

Conditions
Lymphoproliferative DisordersPremalignantMonoclonal B-Cell LymphocytosisChronic Lymphocytic Leukemia
Interventions
OTHER

No intervention

No intervention

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bnai Zion Medical Center

OTHER_GOV

lead

University of Haifa

OTHER

NCT05718986 - Familial B-cell Lymphoproliferative Disorders | Biotech Hunter | Biotech Hunter